Civil & Administrative

#SFHP2600027DDecree of April 13, 2026, Appointment of Director General of the Biomedicine Agency

🇫🇷France··Other·Low Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

The law appoints Marine Jeantet as the Director General of the Biomedicine Agency in France. This change is primarily administrative and signifies new leadership for the agency. Practical impact is likely limited to internal organizational adjustments.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Appointment of Marine Jeantet as Director General of the Biomedicine Agency

Obligations

What this law requires

high

Publish the decree in the Journal officiel de la République française

French government (Premier ministre)
disclosure
high

The Premier ministre must ensure application of this decree within their scope of responsibility

Premier ministre
operational
high

The Minister of Health, Families, Autonomy and Persons with Disabilities must ensure application of this decree within their scope of responsibility

Ministre de la santé, des familles, de l'autonomie et des personnes handicapées
operational

Affected Parties

Biomedicine AgencyMarine Jeantet

Tags

leadership,biomedicine,appointment

More from France

Decree of April 16, 2026 on Appointments (Regional and Departmental Public Finance Directors)

Decree No. 2026-296 of April 17, 2026, on the Classification of the Bouyouni M'Tsangamouji Aerodrome (Mayotte)

Decree of April 14, 2026, Ending Functions at the Minister's Office